131 related articles for article (PubMed ID: 1356014)
1. Hormonal regulation of c-erbB-2 oncogene expression in breast cancer cells.
De Bortoli M; Dati C; Antoniotti S; Maggiora P; Sapei ML
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):21-5. PubMed ID: 1356014
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells.
Dati C; Antoniotti S; Taverna D; Perroteau I; De Bortoli M
Oncogene; 1990 Jul; 5(7):1001-6. PubMed ID: 1973827
[TBL] [Abstract][Full Text] [Related]
3. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
[TBL] [Abstract][Full Text] [Related]
4. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
Singleton TP; Strickler JG
Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
[TBL] [Abstract][Full Text] [Related]
6. Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice.
Wärri AM; Laine AM; Majasuo KE; Alitalo KK; Härkönen PL
Int J Cancer; 1991 Oct; 49(4):616-23. PubMed ID: 1680817
[TBL] [Abstract][Full Text] [Related]
7. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.
Read LD; Keith D; Slamon DJ; Katzenellenbogen BS
Cancer Res; 1990 Jul; 50(13):3947-51. PubMed ID: 1972345
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
9. erbB-2 expression in estrogen-receptor-positive breast-tumor cells is regulated by growth-modulatory reagents.
Taverna D; Antoniotti S; Maggiora P; Dati C; De Bortoli M; Hynes NE
Int J Cancer; 1994 Feb; 56(4):522-8. PubMed ID: 7906679
[TBL] [Abstract][Full Text] [Related]
10. Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells.
Fernandez-Pol JA
Crit Rev Oncog; 1991; 2(2):173-85. PubMed ID: 1677274
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro.
Antoniotti S; Maggiora P; Dati C; De Bortoli M
Eur J Cancer; 1992; 28(2-3):318-21. PubMed ID: 1350452
[TBL] [Abstract][Full Text] [Related]
12. Altered gene expression in drug-resistant human breast cancer cells.
Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641
[TBL] [Abstract][Full Text] [Related]
13. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
Ciardiello F; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam MP; Bianco AR; Tortora G
Int J Cancer; 1993 Feb; 53(3):438-43. PubMed ID: 8094073
[TBL] [Abstract][Full Text] [Related]
15. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Ethier SP; Kokeny KE; Ridings JW; Dilts CA
Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
[TBL] [Abstract][Full Text] [Related]
16. [Interferon-gamma suppresses expression of the HER-2 oncogene in ovarian cancer cells].
Marth C; Müller-Holzner E; Zeimet AG; Greiter E; Cronauer MV; Doppler W; Eibl B; Hynes NE; Daxenbichler G
Gynakol Geburtshilfliche Rundsch; 1992; 32(1):31-4. PubMed ID: 1355379
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
[TBL] [Abstract][Full Text] [Related]
18. HER-2/neu oncogene expression and proliferation in breast cancers.
Bacus SS; Ruby SG; Weinberg DS; Chin D; Ortiz R; Bacus JW
Am J Pathol; 1990 Jul; 137(1):103-11. PubMed ID: 1973597
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-myc, c-Ha-ras1, and c-erbB-2 proto-oncogenes in normal and malignant human breast epithelial cells.
Benz CC; Scott GK; Santos GF; Smith HS
J Natl Cancer Inst; 1989 Nov; 81(22):1704-9. PubMed ID: 2572702
[TBL] [Abstract][Full Text] [Related]
20. Identification of oncogenes in breast tumors and their effects on growth and differentiation.
Groner B; Hynes NE; Kozma S; Redmond S; Saurer S; Schmitt-Ney M; Ball R; Reichmann E; Shöenberger C; Andres AC
Cancer Treat Res; 1988; 40():67-92. PubMed ID: 2908662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
